Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

ABOUT LOWELL FARMS INC.

Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF) is California-based vertically-integrated cannabis company with advanced production capabilities supporting every step of the supply chain, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Founded in 2014 as Indus Holdings, Inc, Lowell Farms grows artisan craft cannabis with a deep love and respect for the plant, and prides itself on using sustainable materials – from seed to sale – to produce an extensive portfolio of award-winning original and licensed brands, including Lowell Herb Co, Cypress Cannabis, MOON, House Weed and Kaizen Medicinals, for licensed retailers statewide.

Investor Note: In addition to the 69,120,995 Subordinate Voting Shares that are listed and trading, there are 200,537,065 Subordinate Voting Shares reserved for issuance pursuant to the redemption rights attached to certain classes of equity shares of Lowell’s subsidiary that are issued and outstanding but not listed and pursuant to the exercise, conversion or vesting of certain outstanding securities of Lowell and Lowell’s subsidiary.  The total number of issued shares assuming all are redeemed, converted or exercised or become vested, as applicable, into the listed class would be 256,195,212.

Maple Leaf is a public Canadian company that focuses on the hemp industry in North America. The Company currently operates a hemp project in California. With over ten years of extensive greenhouse management experience, the Company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic hemp products. Maple Leaf’s long-term objective is to produce hemp oil and to export its products to approved countries.

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies™, Nature’s Heritage™, InHouse™, Bubby’s Baked™, K Fusion™, Kalm Fusion™, and Vibations™. For additional information, visit www.marimedinc.com.

On a mission to bring food self-sufficiency to every community on this planet, Mary Agrotechnologies Inc. is an agricultural technology company that develops, manufactures, and markets automated growing systems integrated with data-driven artificial intelligence. An integrated suite of hardware and software, the ag-tech company’s proprietary automated growing systems make growing various kinds of crops substantially more sustainable, predictable, consistent, and cost-effective. For both at-home growers and commercial indoor operators, the technology platform makes cultivation independent from local climate, which makes farming agnostic of geographical location and season.

Maven Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLAA) owns ‘Maven Cannabis Inc’, a Licensed Producer of cannabis with a 19,500 square foot facility located on a 37 acre industrial site, centrally located in the Village of Lumby, British Columbia. Learn more at www.mavenbrands.ca.

Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market. Medcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products. The Company’s scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.

MindBio is a leading biotech/biopharma company focused on creating novel and emerging treatments for mental health conditions and is conducting world first take-home Microdosing (MB22001) human clinical trials.  MB22001 is MindBio’s lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for take-home microdosing.  MindBio is a leader in microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. MindBio has developed a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants, has a Phase 2a clinical trial just completed microdosing in patients with Major Depressive Disorder and a Phase 2B clinical trial currently underway microdosing in late stage cancer patients experiencing existential distress. The Company has also started dosing in a Phase 2B Depression Trial.   MindBio invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.

Mojave Brands Inc. is a Canadian-based company. Historically, the Company’s main activities have focused on the cannabis industry.   Currently going through a strategic review, Mojave intends to generate shareholder value through recapitalization and investment in or the vending in of revenue generating assets.

 

Molecule works with client-partners to engage in the production of cannabis-infused beverages and edibles.  We provide the infrastructure, know-how, technology, and licenses for craft producers to create consumable cannabis products.  Molecule’s goal is to be the on-ramp for companies wishing to enter into the cannabis beverage and edibles market, but who choose not to go through the significant process of obtaining the required cannabis licences.

Mountain Valley MD Holdings Inc., through its subsidiary Mountain Valley MD Inc. (“MVMD”) is building a health and wellness organization centred around the implementation of patented oral delivery technologies to create industry leading products that are sought out globally. MVMD’s proposition for delivering formulations that have rapid onset, with high bioavailability, with precision dosing technology, will be core to our success across key health and wellness categories.

Contact The Team

How can we help you?

Contact the CSE team to find out more.